Abzena appoints Giovanni Escobar as SVP and Site Head of Bristol, Pennsylvania Operations

CAMBRIDGE, UNITED KINGDOM - Oct 5, 2020 - Abzena, a leading Partner Research Organization (PRO) for biopharmaceutical outsourced solutions from concept to clinic and into GMP manufacturing has announced the appointment of Giovanni Escobar as Senior Vice President (SVP) and Site Head of its Bristol Operations.

With over 27 years’ experience in the Pharmaceutical industry, Giovanni has previously held roles with progressively increasing scope and responsibility at GSK, including Site Quality Head in Brazil and Site Head in Lincoln, Nebraska.  Prior to joining GSK, Giovanni worked for Johnson & Johnson.

Giovanni brings with him extensive end-to-end experience from R&D, new product development, Quality, supply chain, contract manufacturing, network strategy, technology transfers, site expansions, site start-ups, and remediation improvement programs.  He has also previously achieved manufacturing success through the deployment of several operational excellence initiatives.

Before entering the health care industry, he was in the United States Air Force as a Pharmacy Technician.  He received his Bachelor of Science in Biology at Rutgers University in New Brunswick, NJ and Masters of Science in Pharmaceutical Manufacturing at Stevens Institute of Technology in Hoboken, New Jersey.  

ENDS

Notes to editors

About Abzena

Abzena is a leading partner research organization which offers discovery, design, development and cGMP manufacture of biologics, bioconjugates and complex or highly potent small molecules to the global biopharmaceutical industry. From its facilities in the UK and US the company provides its customers with concept to clinic solutions. Abzena is owned by Welsh, Carson, Anderson & Stowe, one of the world’s leading private equity investors. For more information, please see www.abzena.com.